152 related articles for article (PubMed ID: 24329118)
1. Delirium due to intoxication from the novel synthetic tryptamine 5-MeO-DALT.
Jovel A; Felthous A; Bhattacharyya A
J Forensic Sci; 2014 May; 59(3):844-6. PubMed ID: 24329118
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.
Michely JA; Helfer AG; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Oct; 407(25):7831-42. PubMed ID: 26297461
[TBL] [Abstract][Full Text] [Related]
3. 5-MeO-DALT; a novel designer drug on the market causing acute delirium and rhabdomyolysis.
Kalasho A; Vibe Nielsen S
Acta Anaesthesiol Scand; 2016 Oct; 60(9):1332-6. PubMed ID: 27453155
[No Abstract] [Full Text] [Related]
4. Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.
Klein LM; Cozzi NV; Daley PF; Brandt SD; Halberstadt AL
Neuropharmacology; 2018 Nov; 142():231-239. PubMed ID: 29499272
[TBL] [Abstract][Full Text] [Related]
5. Loss of Consciousness and Visual Hallucinations Related to 5-MeO-DALT Intake, a Case Report Confirmed by Toxicological Analyses.
Dufayet L; Langrand J; Alvarez JC; Islam Larabi A
J Anal Toxicol; 2022 Aug; 46(7):e186-e190. PubMed ID: 35365824
[TBL] [Abstract][Full Text] [Related]
6. Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives.
Brandt SD; Kavanagh PV; Dowling G; Talbot B; Westphal F; Meyer MR; Maurer HH; Halberstadt AL
Drug Test Anal; 2017 Jan; 9(1):115-126. PubMed ID: 27100373
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
[TBL] [Abstract][Full Text] [Related]
8. Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.
Cozzi NV; Daley PF
Bioorg Med Chem Lett; 2016 Feb; 26(3):959-964. PubMed ID: 26739781
[TBL] [Abstract][Full Text] [Related]
9. 3-MeO-PCP intoxication in two young men: First in vivo detection in Italy.
Bertol E; Pascali J; Palumbo D; Catalani V; Di Milia MG; Fioravanti A; Mari F; Vaiano F
Forensic Sci Int; 2017 May; 274():7-12. PubMed ID: 28057371
[TBL] [Abstract][Full Text] [Related]
10. The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): a brief review.
Corkery JM; Durkin E; Elliott S; Schifano F; Ghodse AH
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):259-62. PubMed ID: 22683457
[TBL] [Abstract][Full Text] [Related]
11. The hallucinogenic world of tryptamines: an updated review.
Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M
Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
Michely JA; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
[TBL] [Abstract][Full Text] [Related]
13. Investigating the ability of the microbial model Cunninghamella elegans for the metabolism of synthetic tryptamines.
Grafinger KE; Wilke A; König S; Weinmann W
Drug Test Anal; 2019 May; 11(5):721-729. PubMed ID: 30462883
[TBL] [Abstract][Full Text] [Related]
14. An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.
Arunotayanun W; Dalley JW; Huang XP; Setola V; Treble R; Iversen L; Roth BL; Gibbons S
Bioorg Med Chem Lett; 2013 Jun; 23(11):3411-5. PubMed ID: 23602445
[TBL] [Abstract][Full Text] [Related]
15. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
Grafinger KE; Hädener M; König S; Weinmann W
Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
[TBL] [Abstract][Full Text] [Related]
16. A non-fatal intoxication and seven deaths involving the dissociative drug 3-MeO-PCP.
Johansson A; Lindstedt D; Roman M; Thelander G; Nielsen EI; Lennborn U; Sandler H; Rubertsson S; Ahlner J; Kronstrand R; Kugelberg FC
Forensic Sci Int; 2017 Jun; 275():76-82. PubMed ID: 28324770
[TBL] [Abstract][Full Text] [Related]
17. Toxicology and Analysis of Psychoactive Tryptamines.
Malaca S; Lo Faro AF; Tamborra A; Pichini S; Busardò FP; Huestis MA
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291798
[TBL] [Abstract][Full Text] [Related]
18. Deaths associated with new designer drug 5-IT.
Seetohul LN; Maskell PD; De Paoli G; Pounder DJ
BMJ; 2012 Aug; 345():e5625. PubMed ID: 22923530
[No Abstract] [Full Text] [Related]
19. [Determination of Three Types of New Psychoactive Tryptamines in Blood by QuEChERS Combined with UPLC-MS/MS].
Hou W; Wang YY; Zhang Y; Zhang LP; Xin GB; Qin SY; Wang JF
Fa Yi Xue Za Zhi; 2021 Aug; 37(4):516-523. PubMed ID: 34726005
[TBL] [Abstract][Full Text] [Related]
20. Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans.
Barman R; Kumar Bora P; Saikia J; Konwar P; Sarkar A; Kemprai P; Proteem Saikia S; Haldar S; Slater A; Banik D
Phytochemistry; 2024 Feb; 218():113928. PubMed ID: 38035973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
